Literature DB >> 1845890

Activities of heterodimers composed of DNA-binding- and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4.

A A Shepard1, N A DeLuca.   

Abstract

Two mutant strains (vi12 and vi13) of herpes simplex virus that contain insertion mutations in the sequences that encode the DNA-binding domain of viral regulatory protein ICP4 were generated. Both mutations disrupted specific DNA binding and resulted in transcriptionally inactive molecules; however, the ability of the mutant proteins to form dimers was retained. The mutant proteins formed heterodimers with an ICP4 deletion mutant (X25) that is nonfunctional but retains the ability to bind to consensus sites. Significantly elevated levels of early (E or beta) and "leaky late" (beta gamma or gamma 1) gene expression were observed upon coexpression of the insertion mutant and X25 ICP4 polypeptides. While the heterodimers composed of the vi13 and X25 peptides possessed DNA-binding activity, those composed of vi12 and X25 did not, indicating that DNA binding by the heterodimers may not be required for restored activity. Despite significant levels of early gene expression and viral DNA synthesis in vi12-infected X25 cells, true late (gamma 2) mRNA was not synthesized. This indicates that the structural requirements for ICP4 induction of different classes of viral genes may be different.

Mesh:

Substances:

Year:  1991        PMID: 1845890      PMCID: PMC240517     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation.

Authors:  L Su; D M Knipe
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

2.  Intragenic complementation among partial peptides of herpes simplex virus regulatory protein ICP4.

Authors:  A A Shepard; N A DeLuca
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Characterization of the DNA-binding properties of herpes simplex virus regulatory protein ICP4.

Authors:  P Kattar-Cooley; K W Wilcox
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Isolation of herpes simplex virus regulatory protein ICP4 as a homodimeric complex.

Authors:  D W Metzler; K W Wilcox
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Separation of primary structural components conferring autoregulation, transactivation, and DNA-binding properties to the herpes simplex virus transcriptional regulatory protein ICP4.

Authors:  A A Shepard; A N Imbalzano; N A DeLuca
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

7.  Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides.

Authors:  N A DeLuca; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

8.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.

Authors:  N Mermod; E A O'Neill; T J Kelly; R Tjian
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

9.  ICP4-binding sites in the promoter and coding regions of the herpes simplex virus gD gene contribute to activation of in vitro transcription by ICP4.

Authors:  D G Tedder; R D Everett; K W Wilcox; P Beard; L I Pizer
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  DNA nucleotide sequence analysis of the immediate-early gene of pseudorabies virus.

Authors:  A K Cheung
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  33 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression.

Authors:  Dool-Bboon Kim; Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation.

Authors:  Peter Compel; Neal A DeLuca
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.

Authors:  Lauren M Wagner; Jonathan T Lester; Frances L Sivrich; Neal A DeLuca
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

6.  Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells.

Authors:  Padmavathi Sampath; Neal A Deluca
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  DNA-dependent oligomerization of herpes simplex virus type 1 regulatory protein ICP4.

Authors:  Ruhul H Kuddus; Neal A DeLuca
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

8.  A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties.

Authors:  A A Shepard; N A DeLuca
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.

Authors:  B Gu; N DeLuca
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Authors:  M J Carrozza; N A DeLuca
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.